<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03780556</url>
  </required_header>
  <id_info>
    <org_study_id>ASU 5418</org_study_id>
    <nct_id>NCT03780556</nct_id>
  </id_info>
  <brief_title>Lornoxicam With Low Dose Ketamine Versus Pethidine to Control Pain of Acute Renal Colic</brief_title>
  <official_title>Lornoxicam With Low Dose Ketamine Versus Pethidine to Control Pain of Acute Renal Colic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with acute renal colic divided into 2 groups. Group L administered ornoxicam and
      Group P administered pethidine and VAS was recorded for both groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, randomized, double blind clinical study including 120 patients with acute renal
      pain admitted in emergency department. They were randomly assigned to one of two groups using
      a computer-generated table. Group L received lornoxicam 8 mg IV plus 0.15 mg.kg-1 ketamine
      and Group P received pethidine 50 mg IV. Parameters were observed at baseline and after 0,
      15, 30, 45 and 1 hour of drug treatment. The efficacy of the drug was measured by observing:
      patient rated pain, time to pain relief, rate of pain recurrence, the need for rescue
      analgesia, adverse events and functional status.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2, 2016</start_date>
  <completion_date type="Actual">May 2018</completion_date>
  <primary_completion_date type="Actual">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in pain feeling</measure>
    <time_frame>0hours, 1hour,2hours,3hours,4hours after drug administration in both groups</time_frame>
    <description>We assess this through Visual analogue scale score to assess pain due to renal colic, number 10 means maximum pain feeling and 0 means no pain at all.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>No need for more analgesics</measure>
    <time_frame>Registration of analgesic needed for 12h after the attack</time_frame>
    <description>Rescue analgesics administration</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Renal Colic</condition>
  <arm_group>
    <arm_group_label>Lornixicam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients received lornoxicam 8 mg intravenous to control pain</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pethidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients received pethidine 50mg intravenous to control pain</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lornoxicam and mepridine</intervention_name>
    <description>compare the effect of each to control pain</description>
    <arm_group_label>Lornixicam</arm_group_label>
    <arm_group_label>Pethidine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients, who did not administer any analgesics at least within the last two hours. -
             -

          -  Patients aged between 20-60 years.

        Exclusion Criteria:

          -  Patients with previous renal surgery

          -  liver and renal failure

          -  hypersensitivity to lornoxicam, ketamine and pethidine, history of peptic ulcer,

          -  gastrointestinal bleeding and perforation,

          -  hypertensive and history of cardiac diseases

          -  pregnancy and lactation and

          -  urine examination showing more than 5 leukocytes suggestive of pyuria.

          -  patients with hyperthyroidism are excluded
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>ŸêAin Shams University hospitals</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>December 11, 2018</study_first_submitted>
  <study_first_submitted_qc>December 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 19, 2018</study_first_posted>
  <last_update_submitted>December 19, 2018</last_update_submitted>
  <last_update_submitted_qc>December 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Ayman Anis Metry</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>Renal pain</keyword>
  <keyword>lornoxicam</keyword>
  <keyword>pethidine</keyword>
  <keyword>emergency room</keyword>
  <keyword>ketamine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colic</mesh_term>
    <mesh_term>Renal Colic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lornoxicam</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

